Infection Control Today Magazine

Passive Sharps Safety

B. Braun Introduces Next Generation Safety-Engineered Catheter

B. Braun Medical Inc. (B. Braun) will attend INS 2012 with its latest development in safety-engineered medical devices, the Introcan Safety® 3 Closed IV Catheter. The new product includes the proven passive protection from needlestick injuries that has made B. Braun the ...More
5 weeks ago
Posted in News
Needlestick Safety Remains a Concern for Healthcare Professionals

Despite legislation and continued focus across the U.S. to improve sharps safety, needlestick injuries (NSIs) resulting in the exposure to infectious disease continue to be a major issue facing all healthcare professionals. Lynn Hadaway, MEd, RN, BC, CRNI, who has more than ...More
February 7, 2012
Posted in News, PPE & Standard Precautions
FDA Grants 510(k) Clearance for Introcan Safety 3

Expanding its offering of passive safety devices to protect both clinicians and patients from needlestick injuries (NSIs), B. Braun Medical Inc. (B. Braun) recently announced that the Food and Drug Administration (FDA) granted 510(k) clearance of the company’s Introcan ...More
October 19, 2011
Posted in News
Study Raises Ongoing Issue of Passive vs. Active Safety-Engineered Sharps Devices

Any device that endeavors to protect healthcare workers from needlesticks and other percutaneous injuries is a benefit to the occupational safety and health agenda in healthcare institutions, but a recent study is asking clinicians to consider whether passive ...More
November 2, 2010
Posted in Articles
Unilife Corporation Secures FDA 510k Clearance for Tuberculin Syringe

Unilife Corporation today announces that its Unitract Tuberculin (TB) Syringe has received 510(k) market clearance from the Food and Drug Administration (FDA). The Unitract TB syringe is a variant of the Unitract 1mL Insulin Syringe for which Unilife secured FDA clearance ...More
September 1, 2010
Posted in News
Protectus Safety Syringe Earns Patent for Spring Action

Protectus Medical Devices, Inc. announces it has received a notice of allowance from the U.S. Patent and Trademark Office on its patent application describing a spring-activated, automatic, self-sheathing safety syringe. Dr. John Salstrom, CEO of Protectus, says the unique ...More
August 13, 2010
Posted in News